These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8554006

  • 1. Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure.
    Awan NA, Mason DT.
    Am Heart J; 1996 Jan; 131(1):177-85. PubMed ID: 8554006
    [Abstract] [Full Text] [Related]

  • 2. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
    Pichler M, Klein W, Huber K, Pachinger O.
    Wien Med Wochenschr; 1996 Jan; 146(11):228-31. PubMed ID: 8928520
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
    Eberhardt RT, Kevak RM, Kang PM, Frishman WH.
    J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II antagonism: a new avenue of hypertension management.
    Gavras H.
    Blood Press Suppl; 1997 Nov; 1():42-6. PubMed ID: 9285108
    [Abstract] [Full Text] [Related]

  • 5. [Medical angiotensin II-receptor blockade in hypertension and heart failure].
    van Zwieten PA, Lie KI.
    Ned Tijdschr Geneeskd; 1995 Jul 29; 139(30):1529-33. PubMed ID: 7675129
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin receptors: physiology and pharmacology.
    Guthrie GP.
    Clin Cardiol; 1995 Jun 29; 18(6 Suppl 3):III 29-34. PubMed ID: 7634561
    [Abstract] [Full Text] [Related]

  • 11. Losartan in heart failure: preclinical experiences and initial clinical outcomes.
    Sweet CS, Rucinska EJ.
    Eur Heart J; 1994 Dec 29; 15 Suppl D():139-44. PubMed ID: 7713103
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y.
    Can J Cardiol; 1995 Aug 29; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun 23; 37(951):57-8. PubMed ID: 7783693
    [No Abstract] [Full Text] [Related]

  • 16. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
    Krasnikova TL.
    Klin Med (Mosk); 1996 Jun 23; 74(3):17-21. PubMed ID: 8926692
    [No Abstract] [Full Text] [Related]

  • 17. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
    Goldberg AI, Dunlay MC, Sweet CS.
    Am J Cardiol; 1995 Apr 15; 75(12):793-5. PubMed ID: 7717281
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Angiotensin II antagonists].
    Tikkanen I, Tikkanen T.
    Duodecim; 1995 Apr 15; 111(18):1733-5. PubMed ID: 9340266
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.